Recruiting Hereditary Angioedema Studies in Wheaton
About Hereditary Angioedema Clinical Trials in Wheaton
Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.
There are currently 3 hereditary angioedema clinical trials recruiting participants in Wheaton, MD. These studies are seeking a combined 190 participants. Research is being sponsored by ADARx Pharmaceuticals, Inc., Institute for Asthma and Allergy. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hereditary Angioedema Clinical Trials in Wheaton — FAQ
Are there hereditary angioedema clinical trials in Wheaton?
Yes, there are 3 hereditary angioedema clinical trials currently recruiting in Wheaton, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Wheaton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wheaton research site will contact you about next steps.
Are clinical trials in Wheaton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wheaton studies also compensate for your time and travel.
What hereditary angioedema treatments are being tested?
The 3 active trials in Wheaton are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.
Data updated October 17, 2026 from ClinicalTrials.gov